Genenta Science S.p.A.
GNTANext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for GNTA. That does not mean none is planned.
Get an email about GNTA's next catalysts
Track Genenta Science S.p.A. (GNTA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Temferon | Phase 2 | Glioblastoma Multiforme | - | - |
Frequently asked questions
What is in Genenta Science S.p.A.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Genenta Science S.p.A.'s (GNTA) pipeline across Phase 2. Its lead program is Temferon (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Genenta Science S.p.A.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Genenta Science S.p.A. (GNTA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track GNTA biotech catalysts?→
Add GNTA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Genenta Science S.p.A.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.